Unbeaten At Trial, Bayer and Janssen Say Cycle Of Xarelto Lawsuits ‘Needs To Be Stopped’

Early returns haven’t been positive for plaintiffs attorneys, so Xarelto liability theories have been mutating, defense says

Read the full post on Forbes - Pharma & Healthcare